Gefitinib Sandoz

Gefitinib Sandoz is an oral medication used to treat certain types of cancer. This pharmaceutical is designed to target specific proteins in cancer cells, potentially slowing their growth.

Gefitinib Sandoz is primarily used in the treatment of non-small cell lung cancer (NSCLC) that has spread or returned. It works by targeting specific proteins involved in cancer cell growth. Patients often wonder, 'What is Gefitinib Sandoz used for?' This medication is typically prescribed for advanced or metastatic NSCLC with specific genetic markers.

Common effects of Gefitinib Sandoz may include skin rash, diarrhea, and fatigue. Some users may experience appetite loss or nausea. These effects can vary widely among individuals and are not exhaustive.

Gefitinib Sandoz should be handled with care, especially by those with pre-existing medical conditions. It is important to follow the advice of a healthcare provider regarding its use. Always store this medication as directed to maintain its efficacy.

Gefitinib Sandoz may interact with certain medications, including those that affect liver enzymes. It is advisable to discuss all current medications with a healthcare provider to avoid potential interactions. Alcohol consumption should also be considered, as it may affect the body's response to the medication.